PT METRO HEALTHCARE INDONESIA TBK PT Metro Healthcare Indonesia Tbk Share Price
Equities
CARE
ID1000154909
Healthcare Facilities & Services
|
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
| 155 IDR | +7.64% |
|
+10.71% | -3.12% |
| Sales 2022 | 234B 14.27M 1.15B | Sales 2023 | 243B 14.8M 1.19B | Capitalization | 5,320B 325M 26.08B |
|---|---|---|---|---|---|
| Net income 2022 | -93.54B -5.71M -459M | Net income 2023 | -111B -6.77M -544M | EV / Sales 2022 | 68.1 x |
| Net Debt 2022 | 104B 6.33M 509M | Net Debt 2023 | 200B 12.18M 979M | EV / Sales 2023 | 22.7 x |
| P/E ratio 2022 |
-169
x | P/E ratio 2023 |
-48
x | Employees | 742 |
| Yield 2022 * |
-
| Yield 2023 |
-
| Free-Float | 44.55% |
More Fundamentals
* Assessed data
More news
| 1 day | +7.64% | ||
| 1 week | +10.71% | ||
| Current month | +5.44% | ||
| 1 month | +5.44% | ||
| 3 months | -6.63% | ||
| 6 months | -67.71% | ||
| Current year | -3.12% |
1 week
135.00
155.00
1 month
111.00155.00
Current year
110.00192.00
1 year
110.00545.00
3 years
110.00605.00
5 years
105.00605.00
10 years
105.00605.00
| Managers | Title | Age | Since |
|---|---|---|---|
Henry Kembaren
CEO | Chief Executive Officer | 66 | 31/07/19 |
Elisa
DFI | Director of Finance/CFO | - | - |
Idama
PRN | Corporate Officer/Principal | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Chairman | 54 | 31/07/19 | |
Rico Novyanto
BRD | Director/Board Member | 35 | 19/08/21 |
| Name | Weight | AuM | 1st Jan change | Investor Rating |
|---|---|---|---|---|
| 0.41% | 2 M€ | -14.14% | ||
| 0.01% | 4 M€ | -4.41% | - | |
| 0.00% | 117 M€ | +1.54% | - | |
| 0.00% | 7 M€ | +2.68% | - |
| Date | Price | Change | Volume |
|---|---|---|---|
| 29/04/24 | 155 | +7.64% | 448,400 |
| 26/04/24 | 144 | +3.60% | 823,200 |
| 25/04/24 | 139 | -0.71% | 331,600 |
| 24/04/24 | 140 | 0.00% | 1,721,900 |
| 23/04/24 | 140 | 0.00% | 1,668,000 |
End-of-day quote INDONESIA S.E., April 28, 2024
More quotes
PT Metro Healthcare Indonesia Tbk is an Indonesia-based company. The Company operates its business in an integrated health service with hospital under Metro Hospital Group. It is focused on developing technology-based health services and training centers to produce professionals in health services. The Companyâs hospitals consist of mother and child hospitals and type B, type C, and type D general hospitals. The Company offers healthcare service with a range of services and facilities including polyclinic, ICU room, class III inpatient room and Super VIP room ready to cater various type of patients. The Company operates RSIA Bunda Sejahtera, RSU Bina Sehat Mandiri, RSU Metro Hospitals Cikarang, RSU Metro Hospitals Cikupa, RSU Kartini, and RSIA Santo Yusuf. Its subsidiaries include PT Metro Global Medika, PT Metro Healthcare Technologies, PT Metro Medika Abadi, PT Mitra Adika Buana, PT Indah Nusa Indonesia, PT Sejahtera Berkah Berdikari and PT Berkarya Sejahtera Gemilang.
Calendar
26/05/2024
- Q4 2023 Earnings Release (Projected)
| 1st Jan change | Capi. | |
|---|---|---|
| -3.12% | 317M | |
| -17.07% | 16.85B | |
| +3.60% | 12.34B | |
| +5.64% | 11.77B | |
| +4.87% | 10.28B | |
| +25.36% | 8.38B | |
| -0.95% | 7.88B | |
| +22.18% | 7.29B | |
| +5.77% | 6.75B | |
| +52.00% | 4.69B |
- Stock Market
- Equities
- CARE Stock
